[HTML][HTML] Global colorectal cancer burden in 2020 and projections to 2040

Y Xi, P Xu - Translational oncology, 2021 - Elsevier
As the third most common malignancy and the second most deadly cancer, colorectal
cancer (CRC) induces estimated 1.9 million incidence cases and 0.9 million deaths …

Screening and prevention of colorectal cancer

P Kanth, JM Inadomi - Bmj, 2021 - bmj.com
Mortality from colorectal cancer is reduced through screening and early detection; moreover,
removal of neoplastic lesions can reduce cancer incidence. While understanding of the risk …

Histopathology images predict multi-omics aberrations and prognoses in colorectal cancer patients

PC Tsai, TH Lee, KC Kuo, FY Su, TLM Lee… - Nature …, 2023 - nature.com
Histopathologic assessment is indispensable for diagnosing colorectal cancer (CRC).
However, manual evaluation of the diseased tissues under the microscope cannot reliably …

Epigenetic alterations in the gastrointestinal tract: current and emerging use for biomarkers of cancer

WM Grady - Advances in cancer research, 2021 - Elsevier
Colorectal cancer is a leading cause of cancer related deaths worldwide. One of the
hallmarks of cancer and a fundamental trait of virtually all gastrointestinal cancers is …

Terminology, molecular features, epidemiology, and management of serrated colorectal neoplasia

SD Crockett, ID Nagtegaal - Gastroenterology, 2019 - Elsevier
In addition to the adenoma to carcinoma sequence, colorectal carcinogenesis can occur via
the serrated pathway. Studies have focused on clarification of categories and molecular …

Microsatellite instability as a biomarker for PD-1 blockade

JC Dudley, MT Lin, DT Le, JR Eshleman - Clinical Cancer Research, 2016 - AACR
Initial results by Le and colleagues, which were published in the June 25, 2015 issue of the
New England Journal of Medicine, report significant responses of cancers with microsatellite …

Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity

L Mangiante, N Alcala, A Sexton-Oates, A Di Genova… - Nature Genetics, 2023 - nature.com
Malignant pleural mesothelioma (MPM) is an aggressive cancer with rising incidence and
challenging clinical management. Through a large series of whole-genome sequencing …

Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis

K Mima, R Nishihara, ZR Qian, Y Cao, Y Sukawa… - Gut, 2016 - gut.bmj.com
Objective Accumulating evidence links the intestinal microbiota and colorectal
carcinogenesis. Fusobacterium nucleatum may promote colorectal tumour growth and …

Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells

U Testa, E Pelosi, G Castelli - Medical Sciences, 2018 - mdpi.com
Colon cancer is the third most common cancer worldwide. Most colorectal cancer
occurrences are sporadic, not related to genetic predisposition or family history; however, 20 …

Fusobacterium nucleatum and T cells in colorectal carcinoma

K Mima, Y Sukawa, R Nishihara, ZR Qian… - JAMA …, 2015 - jamanetwork.com
Importance Evidence indicates a complex link between gut microbiome, immunity, and
intestinal tumorigenesis. To target the microbiota and immunity for colorectal cancer …